biologic

Genotropin

somatropin

Loss of exclusivityJanuary 2010projected — 12-year biologic exclusivity estimate
CompanyPharmacia & Upjohn Company LLC

Drug detail

Brand nameGenotropin
Active ingredientsomatropin
Strength0.2MG
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalJanuary 1998
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Genotropin patent cliff — loss of exclusivity January 2010 | CliffBio